MedTrace Logo

Supportive Outcomes Through Listening, Validation, and Empowerment

NCT06587594 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2024-09-19

No results posted yet for this study

Summary

This research aims to pilot an intervention that will provide practitioners and clinicians with evidenced-based behavioral health strategies for working with autistic adults. The findings will contribute to the needed, yet sparse research of evidence-based behavioral health interventions for this population.

The guiding research aims for this study are:

1. To implement a small-scale pilot study aimed at refining the Solution Focused Brief Therapy (SFBT) and protocol for use with autistic adults based on clinician expertise and lived experience.
2. To test the feasibility and acceptability of the SFBT. Namely, how well the intervention is received by this population and if participants can attend and engage in all 4 sessions.
3. To evaluate outcomes before and after the intervention and assess for any improvements through valid and reliable measurements of behavioral health outcomes.

This research aims to answer the following research questions:

1. What is the retention rate of participants in the 4-weekly sessions of the SOLVE program?
2. Do participants show progress in their self-identified goals after the intervention?
3. What are the experiences and satisfaction rates of participants in participating in a four-session SFBT intervention?
4. Do participants report higher scores in quality of life and lower depressive and anxiety scores between baseline and immediately post-intervention?

The five autistic participants will participate in four one-on-one weekly SFBT sessions conducted by licensed mental health professionals. The intervention is expected to take four to 5 weeks, allowing for cancelations and rescheduling as needed.

Conditions

  • Autism Spectrum Disorder (ASD)

Interventions

BEHAVIORAL

Solution Focused Brief Therapy

A behavioral health intervention designed to help autistic adults to make a positive change in their life using strength-based approach.

Sponsors & Collaborators

  • University of Texas at Austin

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-14
Primary Completion
2025-01-31
Completion
2025-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06587594 on ClinicalTrials.gov